Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) has terminated its CEO Rajesh Shrotriya and has appointed Joseph Turgeon as the company’s new CEO. Turgeon, who was previously the COO, will still maintain his position as President of the company.
Spectrum’s Board of Directors announced several other changes to the company’s management team as well. Stuart Krassnerhas, the current Director, has been appointed as the new Chairman of the Board. Thomas Riga will be taking up Turgeon’s place as COO. All the announced changes went into effect immediately.
The company is optimistic about its changes.
Featured Image: twitter
